StockViz
RANKINGS
Cipla Limited
NSE:CIPLA.NS
Sector
Location
Market Cap
USD 14.24 B
Share Price
USD 17.06
Avg Daily Volume
1,583,273
Change (1 day)
0.62%
Change (1 year)
-4.63%
Change (YTD)
-4.47%
Cipla Limited Key Metrics 2015 - 2025
This table shows the Key Metrics for Cipla Limited going from 2015 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Eli Lilly and Company
USD 798.89
LLY
+22.45
2.89%
AbbVie Inc.
USD 190.55
ABBV
+3.44
1.84%
Roche Holding AG
USD 348.84
RO.SW
+11.26
3.33%
AstraZeneca PLC
USD 144.94
AZN.L
+4.91
3.51%
Merck & Co., Inc.
USD 83.98
MRK
+2.37
2.90%
Amgen Inc.
USD 309.22
AMGN
+3.53
1.16%
Pfizer Inc.
USD 25.36
PFE
+0.22
0.88%
Gilead Sciences, Inc.
USD 113.56
GILD
+3.39
3.08%
Sanofi
USD 99.61
SAN.PA
+2.58
2.66%
Bristol-Myers Squibb Company
USD 48.98
BMY
+0.96
2.00%
Chugai Pharmaceutical Co., Ltd.
USD 49.58
4519.T
+1.01
2.08%
GSK plc
USD 18.62
GSK.L
+0.40
2.17%
Regeneron Pharmaceuticals, Inc.
USD 572.39
REGN
+11.46
2.04%
Cencora, Inc.
USD 293.44
COR
+0.47
0.16%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.97
600276.SS
-0.01
-0.09%
Takeda Pharmaceutical Company Limited
USD 29.83
4502.T
+0.18
0.60%
Daiichi Sankyo Company, Limited
USD 25.12
4568.T
+0.25
1.00%
Haleon plc
USD 4.87
HLN.L
+0.07
1.38%
Ucb S.A.
USD 209.27
UCB.BR
+6.46
3.18%
BeOne Medicines Ltd.
USD 294.83
ONC
-0.76
-0.26%